170 related articles for article (PubMed ID: 8130824)
1. [IVF in sterility related to ovarian dystrophy].
Chrétien MF; Guerrier C; Denis A; Malkani K
Contracept Fertil Sex; 1993 Dec; 21(12):907-10. PubMed ID: 8130824
[TBL] [Abstract][Full Text] [Related]
2. [Comparative randomized controlled study between human follicle- stimulating hormone (FSH-HP) and human menopausal gonadotropins (hMG) in in vitro fertilization].
Mayenga JM; Belaisch-Allart J; Chouraqui A; Tesquier L; Serkine AM; Cohen J; Plachot M; Mandelbaum J
Contracept Fertil Sex; 1997 May; 25(5):371-4. PubMed ID: 9273107
[TBL] [Abstract][Full Text] [Related]
3. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2).
Eijkemans MJ; Polinder S; Mulders AG; Laven JS; Habbema JD; Fauser BC
Hum Reprod; 2005 Oct; 20(10):2830-7. PubMed ID: 16006473
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
Andersen AN; Devroey P; Arce JC
Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
[TBL] [Abstract][Full Text] [Related]
6. Ovarian stimulation and intrauterine insemination in women aged 40 years or more.
Wiser A; Shalom-Paz E; Reinblatt SL; Son WY; Das M; Tulandi T; Holzer H
Reprod Biomed Online; 2012 Feb; 24(2):170-3. PubMed ID: 22197126
[TBL] [Abstract][Full Text] [Related]
7. [Pregnancy results in in vitro fertilization in one case of luteinized-unruptured-follicle syndrome].
Letouzey V; Reyftmann L; Hamamah S; Hédon B
Gynecol Obstet Fertil; 2008 Jan; 36(1):60-2. PubMed ID: 18248842
[TBL] [Abstract][Full Text] [Related]
8. [Influence of infertility etiology and follicular stimulation protocols on pregnancy outcomes by in vitro fertilization].
Merviel P; Antoine JM; Alvarez S; Cornet D; Plachot M; Mandelbaum J; Uzan S; Salat-Baroux J
Contracept Fertil Sex; 1996 Feb; 24(2):157-62. PubMed ID: 8611938
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of human menopausal gonadotropins purified as to their FSH content in anovulatory sterility presenting a difficult treatment problem].
Emperaire JC; Ruffié A; Audebert AJ
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):621-6. PubMed ID: 3117873
[TBL] [Abstract][Full Text] [Related]
10. [Tubal sterility. What treatment to propose: IVF or surgery?].
Chardon C; Boulieu D; Rochet Y; Payan F; Ayzac L
Rev Fr Gynecol Obstet; 1992 Jun; 87(6):355-60. PubMed ID: 1631478
[TBL] [Abstract][Full Text] [Related]
11. [A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro].
Daya S; Gumby J; Hughes EG; Collins JA; Sagle MA
Contracept Fertil Sex; 1995 Dec; 23(12):766-71. PubMed ID: 8556078
[TBL] [Abstract][Full Text] [Related]
12. A retrospective review comparing the use of Gonal-F and Metrodin-HP for in-vitro fertilisation (IVF).
Lee C; Mak FS; Keith J; Welsh D; Yapp P; Chin R
Med J Malaysia; 2003 Mar; 58(1):94-8. PubMed ID: 14556331
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of female infertility due to hyperandrogenism].
Cordray JP; Siboulet B; Merceron RE; Guillerd X; Nys P
Rev Fr Gynecol Obstet; 1994 May; 89(5):255-66. PubMed ID: 8036387
[TBL] [Abstract][Full Text] [Related]
14. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
16. [Treatment options of clomiphene-resistant polycystic ovary syndrome related infertility].
Liang X; Zhuang G; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):591-3. PubMed ID: 11372407
[TBL] [Abstract][Full Text] [Related]
17. In-vitro fertilisation treatment: factors affecting its results and outcome.
Qublan HS; Malkawi HY; Tahat YA; Areidah S; Nusair B; Khreisat BM; Al-Quraan G; Abu-Assaf A; Hadaddein MF; Abu-Jassar H
J Obstet Gynaecol; 2005 Oct; 25(7):689-93. PubMed ID: 16263545
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
19. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
[TBL] [Abstract][Full Text] [Related]
20. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
